Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2018 AND VI 32 AND IP 8
Results: 10
1
2
Drug Repurposing in Parkinson's Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents.
- Published in:
- 2018
- By:
- Publication type:
- journal article
4
Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders.
- Published in:
- 2018
- By:
- Publication type:
- journal article
5
Amantadine Extended-Release (GOCOVRI<sup>™</sup>): A Review in Levodopa-Induced Dyskinesia in Parkinson's Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System.
- Published in:
- 2018
- By:
- Publication type:
- journal article
7
Cladribine Tablets: A Review in Relapsing MS.
- Published in:
- 2018
- By:
- Publication type:
- journal article
8
Correction to: Treatment Strategies for Dravet Syndrome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
9
Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany.
- Published in:
- 2018
- By:
- Publication type:
- journal article
10
The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article